Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers
Clinical trial NCT02304185 · COMPLETED
Trial details
- NCT number
- NCT02304185
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.